Related Experiment Video
Updated: Mar 18, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Premature birth and insulin resistance in infancy: A prospective cohort study
Vikas Payal1, Rakesh Jora1, Pramod Sharma1
1Department of Pediatrics, Dr. S.N. Medical College, Umaid Hospital, Jodhpur, Rajasthan, India.
Insights
Preterm birth and small for gestational age status are significant risk factors for developing insulin resistance in infancy. These conditions can predict future metabolic health challenges early in life.
Area of Science:
- Neonatal Research
- Metabolic Health
- Pediatric Endocrinology
Background:
- Infant insulin sensitivity is crucial for long-term metabolic health.
- Prematurity and intrauterine growth restriction are potential risk factors for later metabolic dysfunction.
- Early identification of infants at risk for insulin resistance is essential for timely intervention.
Purpose of the Study:
- To investigate the role of prematurity and small for gestational age (SGA) status in predicting insulin sensitivity during infancy.
- To identify key variables that predict insulin resistance in infants.
- To establish the early development of insulin resistance in preterm infants.
Main Methods:
- A prospective study involving preterm appropriate for gestational age (AGA), preterm SGA, term SGA, and term AGA infants.
- Anthropometric assessments were conducted at birth and at 3, 6, and 9 months.
- Fasting plasma glucose and serum insulin levels were measured at 9 months to calculate insulin resistance using the homeostasis model assessment (HOMA-2).
Main Results:
- Preterm AGA, preterm SGA, and term SGA infants exhibited significantly higher insulin resistance compared to term AGA controls.
- Small for gestational age (SGA) status was a more significant predictor of insulin resistance than gestational age, weight-for-length, or ponderal index.
- No significant difference in insulin resistance was observed between preterm SGA and preterm AGA infants.
Conclusions:
- Preterm birth is identified as a significant risk factor for the future development of insulin resistance.
- Insulin resistance can manifest as early as infancy in infants born preterm.
- SGA status is a critical predictor of infant insulin resistance, highlighting the importance of monitoring growth and metabolic parameters.
Objective:
This study was done to determine the role of prematurity and other variables to predict insulin sensitivity in infancy.
Subjects And Methods:
In this prospective study, 36 preterm appropriate for gestational age (AGA), 11 preterm small for gestational age (SGA), and 17 term SGA included as study cohort and 36 term AGA as control cohort. Detailed anthropometry assessment was performed at birth, 3, 6, and 9 months and at 9 months, fasting plasma glucose and serum insulin was done. Insulin resistance was determined by using homeostasis model assessment version 2.
Results:
It is found that preterm AGA (mean difference 0.617, 95% confidence interval [CI]; 0.43-0.80, P = 0.0001), preterm SGA (mean difference 0.764, 95% CI; 0.44-1.09, P = 0.0001), and term AGA (mean difference 0.725, 95% CI; 0.49-0.96, P = 0.0001) group had significantly higher insulin resistance than control. There was no significant difference in between preterm SGA and preterm AGA (mean difference 0.147 95% CI; -0.13-0.42, P = 0.927). In multiple regression models, SGA status (β =0.505) was more significant predictor of insulin resistance index than gestational age (β = -0.481), weight-for-length (β =0.315), and ponderal index (β = -0.194).
Conclusion:
Preterm birth is a risk factor for the future development of insulin resistance which may develop as early as infancy.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: The Receptor and Signaling Pathways

